NORTHBROOK, Ill., July 31,
2024 /PRNewswire/ -- Stepan Company (NYSE: SCL) today
reported:
Second Quarter 2024 Highlights
- Reported net income was $9.5
million, down 25% versus prior year. Adjusted net
income(1) was $9.4
million, down 22% versus prior year, largely due to a higher
effective tax rate in 2024.
- Pre-tax earnings were negatively impacted by $18.9 million due to higher operating costs at
our Millsdale site, primarily related to a flood event
($11.8 million), pre-commissioning
expenses at our new Alkoxylation investment in Pasadena, Texas ($3.6
million) and expenses related to a criminal
fraud event at a subsidiary in Asia ($3.5
million).
- EBITDA(2) was $47.9
million and Adjusted EBITDA(2) was $47.7 million, up 3% and 4% respectively,
year-over-year.
- Global sales volume was up 4% year-over-year. Surfactant and
Polymer sales volume was up 5% and 2%, respectively.
- Cash from Operations was $29.5
million during the quarter. Free cash flow(3) for
the quarter was slightly negative due to the higher expenses noted
above.
- The Company is on track to deliver its $50 million cost out goal for 2024 and recognized
$2.7 million in pre-tax savings, net
of the higher operating costs at Millsdale, in the second
quarter.
First Half 2024 Highlights
- Reported net income was $23.4
million, down 19% versus prior year. Adjusted net
income(1) was $24.1
million, down 16% year-over-year, largely due to a higher
effective tax rate in 2024.
- EBITDA(2) was $98.0
million and Adjusted EBITDA(2) was $98.9 million, up 3% and 5% respectively,
year-over-year.
- Global sales volume was up 2% year-over-year. Global sales
volume, excluding declines in our Agricultural and commodity
Phthalic Anhydride businesses, was up 5%.
"Second quarter earnings were significantly impacted by
higher operational expenses at our Millsdale site, start up costs
related to our new Pasadena
investment and a criminal social engineering event that targeted
one of our Asia subsidiaries,
leading to unexpected expense in the quarter. We are actively
investigating this fraud event with the assistance of
outside counsel, and to date, we have not found any evidence of
additional fraudulent activity," said Scott
Behrens, President and Chief Executive
Officer. "From a top line perspective, we continue to be
pleased with several of our core markets continuing to deliver
volume growth. Surfactants experienced double-digit
volume growth within the Laundry and Cleaning, Construction and
Industrial Solutions and Oilfield end markets and also with our
Distribution partners. Latin America Surfactant volumes grew
double digits as we recovered Consumer volumes in Mexico and we experienced strong volume growth
within several end markets in Brazil, inclusive of double digit Agricultural
growth. North American and European Agricultural volumes
remained soft and below our second quarter expectations.
Rigid and Specialty Polyols volumes grew during the quarter.
Global margins were in line with expectations despite unfavorable
product mix. Despite the significant expenses incurred during
the quarter, we delivered adjusted EBITDA growth of 4%."
Financial
Summary
|
|
|
|
Three Months
Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
($ in thousands,
except per share data)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
Net Sales
|
|
$
|
556,405
|
|
|
$
|
579,975
|
|
|
|
(4)
|
%
|
|
$
|
1,107,823
|
|
|
$
|
1,231,411
|
|
|
|
(10)
|
%
|
Operating
Income
|
|
$
|
18,667
|
|
|
$
|
17,809
|
|
|
|
5
|
%
|
|
$
|
38,836
|
|
|
$
|
38,866
|
|
|
|
(0)
|
%
|
Net Income
|
|
$
|
9,521
|
|
|
$
|
12,684
|
|
|
|
(25)
|
%
|
|
$
|
23,414
|
|
|
$
|
28,826
|
|
|
|
(19)
|
%
|
Earnings per Diluted
Share
|
|
$
|
0.42
|
|
|
$
|
0.55
|
|
|
|
(24)
|
%
|
|
$
|
1.02
|
|
|
$
|
1.25
|
|
|
|
(18)
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted Net Income
*
|
|
$
|
9,396
|
|
|
$
|
12,057
|
|
|
|
(22)
|
%
|
|
$
|
24,052
|
|
|
$
|
28,476
|
|
|
|
(16)
|
%
|
Adjusted Earnings
per
Diluted Share *
|
|
$
|
0.41
|
|
|
$
|
0.53
|
|
|
|
(23)
|
%
|
|
$
|
1.05
|
|
|
$
|
1.24
|
|
|
|
(15)
|
%
|
|
|
* See Table II for
reconciliations of non-GAAP adjusted net income and adjusted
earnings per diluted share.
|
|
Percentage Change in Net Sales
Net sales in the second quarter of 2024 decreased 4%
year-over-year primarily due to lower selling prices that were
mainly attributable to the pass-through of lower raw material costs
and less favorable product mix. These lower selling prices
were partially offset by a 4% increase in global sales volume.
|
|
Three Months
Ended
June 30, 2024
|
|
|
Six Months Ended
June 30, 2024
|
|
Volume
|
|
|
4
|
%
|
|
|
2
|
%
|
Selling Price &
Mix
|
|
|
(8)
|
%
|
|
|
(13)
|
%
|
Foreign
Translation
|
|
|
(—)
|
%
|
|
|
1
|
%
|
Total
|
|
|
(4)
|
%
|
|
|
(10)
|
%
|
Segment
Results
|
|
|
|
|
Three Months
Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
($ in
thousands)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
Net
Sales
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Surfactants
|
|
$
|
379,795
|
|
|
$
|
391,686
|
|
|
|
(3)
|
%
|
|
$
|
770,615
|
|
|
$
|
859,514
|
|
|
|
(10)
|
%
|
Polymers
|
|
$
|
159,757
|
|
|
$
|
164,515
|
|
|
|
(3)
|
%
|
|
$
|
305,265
|
|
|
$
|
325,642
|
|
|
|
(6)
|
%
|
Specialty
Products
|
|
$
|
16,853
|
|
|
$
|
23,774
|
|
|
|
(29)
|
%
|
|
$
|
31,943
|
|
|
$
|
46,255
|
|
|
|
(31)
|
%
|
Total Net
Sales
|
|
$
|
556,405
|
|
|
$
|
579,975
|
|
|
|
(4)
|
%
|
|
$
|
1,107,823
|
|
|
$
|
1,231,411
|
|
|
|
(10)
|
%
|
|
|
Three Months
Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
($ in thousands, all
amounts pre-tax)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
Operating
Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Surfactants
|
|
$
|
17,062
|
|
|
$
|
15,140
|
|
|
|
13
|
%
|
|
$
|
43,142
|
|
|
$
|
42,196
|
|
|
|
2
|
%
|
Polymers
|
|
$
|
13,597
|
|
|
$
|
16,321
|
|
|
|
(17)
|
%
|
|
$
|
21,979
|
|
|
$
|
26,325
|
|
|
|
(17)
|
%
|
Specialty
Products
|
|
$
|
7,319
|
|
|
$
|
3,773
|
|
|
|
94
|
%
|
|
$
|
11,587
|
|
|
$
|
6,302
|
|
|
|
84
|
%
|
Total Segment
Operating Income
|
|
$
|
37,978
|
|
|
$
|
35,234
|
|
|
|
8
|
%
|
|
$
|
76,708
|
|
|
$
|
74,823
|
|
|
|
3
|
%
|
Corporate
Expenses
|
|
$
|
(19,311)
|
|
|
$
|
(17,425)
|
|
|
|
11
|
%
|
|
$
|
(37,872)
|
|
|
$
|
(35,957)
|
|
|
|
5
|
%
|
Consolidated
Operating Income
|
|
$
|
18,667
|
|
|
$
|
17,809
|
|
|
|
5
|
%
|
|
$
|
38,836
|
|
|
$
|
38,866
|
|
|
|
(0)
|
%
|
|
|
Three Months
Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
($ in
millions)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Surfactants
|
|
$
|
35.0
|
|
|
$
|
31.1
|
|
|
|
13
|
%
|
|
$
|
78.6
|
|
|
$
|
73.5
|
|
|
|
7
|
%
|
Polymers
|
|
$
|
21.8
|
|
|
$
|
24.6
|
|
|
|
(11)
|
%
|
|
$
|
38.2
|
|
|
$
|
42.9
|
|
|
|
(11)
|
%
|
Specialty
Products
|
|
$
|
8.8
|
|
|
$
|
5.2
|
|
|
|
69
|
%
|
|
$
|
14.6
|
|
|
$
|
9.1
|
|
|
|
60
|
%
|
Unallocated Corporate
|
|
$
|
(17.7)
|
|
|
$
|
(14.2)
|
|
|
|
25
|
%
|
|
$
|
(33.4)
|
|
|
$
|
(30.6)
|
|
|
|
9
|
%
|
Consolidated
EBITDA
|
|
$
|
47.9
|
|
|
$
|
46.7
|
|
|
|
3
|
%
|
|
$
|
98.0
|
|
|
$
|
94.9
|
|
|
|
3
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Surfactants
|
|
$
|
35.0
|
|
|
$
|
31.0
|
|
|
|
13
|
%
|
|
$
|
78.6
|
|
|
$
|
73.4
|
|
|
|
7
|
%
|
Polymers
|
|
$
|
21.8
|
|
|
$
|
24.6
|
|
|
|
(11)
|
%
|
|
$
|
38.2
|
|
|
$
|
42.9
|
|
|
|
(11)
|
%
|
Specialty
Products
|
|
$
|
8.8
|
|
|
$
|
5.2
|
|
|
|
69
|
%
|
|
$
|
14.6
|
|
|
$
|
9.1
|
|
|
|
60
|
%
|
Unallocated Corporate
|
|
$
|
(17.9)
|
|
|
$
|
(15.0)
|
|
|
|
19
|
%
|
|
$
|
(32.5)
|
|
|
$
|
(30.9)
|
|
|
|
5
|
%
|
Consolidated
Adjusted EBITDA
|
|
$
|
47.7
|
|
|
$
|
45.8
|
|
|
|
4
|
%
|
|
$
|
98.9
|
|
|
$
|
94.5
|
|
|
|
5
|
%
|
Consolidated adjusted EBITDA increased $1.9 million, or 4%, year-over-year as a 4%
increase in sales volume and slight margin improvement more than
offset $11.8 million of negative
impact associated with the operational and infrastructure issues at
the Millsdale site.
- Surfactant net sales were $379.8
million for the quarter, a 3% decrease versus the prior
year. Selling prices were down 8% primarily due to the pass-through
of lower raw material costs, less favorable product mix and
competitive pricing pressures in Latin
America. Sales volume was up 5% year-over-year as double
digit growth within the Laundry and Cleaning, Construction and
Industrial Solutions and Oilfield end markets and with our
distribution partners was offset by lower Agricultural demand due
to continued customer and channel inventory destocking. Foreign
currency translation had a negligible impact on net sales.
Surfactant adjusted EBITDA(2) for the quarter increased
$4.0 million, or 13%, versus the
prior year. This increase was primarily driven by the 5% growth in
sales volume and slight margin improvement that was partially
offset by pre-operating expenses at the Company's new alkoxylation
facility being built in Pasadena,
Texas and higher expenses associated with operational and
infrastructure issues at the Millsdale plant.
- Polymer net sales were $159.8
million for the quarter, a 3% decrease versus the prior
year. Selling prices decreased 6%, primarily due to the
pass-through of lower raw material costs. Sales volume increased 2%
in the quarter as a 2% increase in global Rigid Polyols demand and
a 28% increase within the Specialty Polyols business was partially
offset by lower commodity Phthalic Anhydride volume. Foreign
currency translation positively impacted net sales by 1%. Polymer
adjusted EBITDA(2) decreased $2.8
million, or 11%, versus the prior year driven by a non-cash
Phthalic Anhydride-related catalyst write-off at the Millsdale site
and higher costs incurred at Millsdale due to operational and
infrastructure issues.
- Specialty Product net sales were $16.9
million for the quarter, a 29% decrease versus the prior
year, primarily due to lower prices. Sales volume was down 2%
versus the prior year while adjusted EBITDA(2) increased
$3.6 million, or 69%. The increase in
adjusted EBITDA(2) was primarily due to higher unit
margins within the medium chain triglycerides product line.
Asia Event
On July 18, 2024, we determined
that a Company subsidiary in Asia
had been the victim of a criminal social engineering scheme which
resulted in fraudulently induced outbound payments. The
Company immediately launched an investigation, led by outside
counsel, to determine the full extent of the fraud
scheme and related potential exposure. The investigation is
ongoing. We initiated contact with our banks and law
enforcement authorities in an effort to, among other things,
recover the transferred funds. We have not found any evidence
of additional fraudulent activity and we believe this is an
isolated and contained event. This incident did not result in
any unauthorized access to our information systems or any
confidential customer information or other data that we maintain.
The Company has recognized a $3.5
million pre-tax charge for the quarter ended June 30, 2024, and, while the investigation is
ongoing, the Company expects to record a charge in a similar amount
in the third quarter of 2024 as a result of this event. While this
matter will result in some additional near-term expenses, the
Company does not expect this incident to otherwise have a material
impact on its business.
Outlook
"We expect second half EBITDA to improve versus the prior
year based on continued volume growth and a significant reduction
in second half operational expenses at our Millsdale site, which
was the majority of the significant variance in second quarter
expenses. The on-going recovery in Rigid Polyols and
the expected second half of the year recovery of the Agricultural
Chemicals business should drive improved earnings," said
Scott Behrens, President and Chief
Executive Officer. "Free cash flow should continue to improve
versus prior year driven by the completion of our Pasadena investment, the growth in market
volumes, and our continued focus on cost reduction. We
believe we are positioned to deliver full year Adjusted EBITDA
growth and positive free cash flow."
Notes
|
(1) Adjusted net
income and adjusted earnings per share are non-GAAP measures which
exclude deferred compensation income/expense, cash-settled stock
appreciation rights (SARs) income/expense, certain environmental
remediation-related costs as well as other significant and
infrequent/non-recurring items. See Table II for reconciliations of
non-GAAP adjusted net income and adjusted earnings per diluted
share.
|
|
(2) EBITDA and
adjusted EBITDA are non-GAAP measures. See Table VI for
calculations and GAAP reconciliations of EBITDA and adjusted
EBITDA.
|
|
(3) Free Cash Flow
is a non-GAAP measure and reflects cash generated from operations
minus capital expenditures.
|
|
Conference Call
Stepan Company will host a conference call to discuss its second
quarter results at 9:00 a.m. ET
(8:00 a.m. CT) on July 31, 2024. The call can be accessed by phone
and webcast. To access the call by phone, please click on this
Registration Link, complete the form and you will be provided
with dial in details and a PIN. To avoid delays, we encourage
participants to dial into the conference call ten minutes ahead of
the scheduled start time. The webcast can be accessed through
the Investors/Conference Calls page at www.stepan.com. A
webcast replay of the conference call will be available at the same
location shortly after the call.
Supporting Slides
Slides supporting this press release will be made available at
www.stepan.com through the Investors/Presentations page
at approximately the same time as this press release is issued.
Corporate Profile
Stepan Company is a major manufacturer of specialty and
intermediate chemicals used in a broad range of industries. Stepan
is a leading merchant producer of surfactants, which are the key
ingredients in consumer and industrial cleaning and disinfection
compounds and in agricultural and oilfield solutions. The Company
is also a leading supplier of polyurethane polyols used in the
expanding thermal insulation market, and CASE (Coatings, Adhesives,
Sealants, and Elastomers) industries.
Headquartered in Northbrook,
Illinois, Stepan utilizes a network of modern production
facilities located in North and South
America, Europe and
Asia.
The Company's common stock is traded on the New York Stock
Exchange (NYSE) under the symbol SCL. For more information about
Stepan Company please visit the Company online at
www.stepan.com
More information about Stepan's sustainability program can be
found on the Sustainability page at www.stepan.com
Certain information in this news release consists of
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. These statements
include statements about Stepan Company's plans, objectives,
strategies, financial performance and outlook, trends, the amount
and timing of future cash distributions, prospects or future events
and involve known and unknown risks that are difficult to predict.
As a result, Stepan Company's actual financial results,
performance, achievements or prospects may differ materially from
those expressed or implied by these forward-looking statements. In
some cases, you can identify forward-looking statements by the use
of words such as "may," "could," "expect," "intend," "plan,"
"seek," "anticipate," "believe," "estimate," "guidance," "predict,"
"potential," "continue," "likely," "will," "would," "should,"
"illustrative" and variations of these terms and similar
expressions, or the negative of these terms or similar expressions.
Such forward-looking statements are necessarily based upon
estimates and assumptions that, while considered reasonable by
Stepan Company and its management based on their knowledge and
understanding of the business and industry, are inherently
uncertain. These statements are not guarantees of future
performance, and stockholders should not place undue reliance on
forward-looking statements.
There are a number of risks, uncertainties and other
important factors, many of which are beyond Stepan Company's
control, that could cause actual results to differ materially from
the forward-looking statements contained in this news release. Such
risks, uncertainties and other important factors include, among
other factors, the risks, uncertainties and factors described in
Stepan Company's Form 10-K, Form 10-Q and Form 8-K reports and
exhibits to those reports, and include (but are not limited to)
risks and uncertainties related to accidents, unplanned
production shutdowns or disruptions in manufacturing facilities;
reduced demand due to customer product reformulations or new
technologies; our inability to successfully develop or introduce
new products; compliance with laws; our ability to identify
suitable acquisition candidates and successfully complete and
integrate acquisitions; global competition; volatility of raw
material and energy costs and supply; disruptions in transportation
or significant changes in transportation costs; downturns in
certain industries and general economic downturns; international
business risks, including currency exchange rate fluctuations,
legal restrictions and taxes; unfavorable resolution of litigation
against us; maintaining and protecting intellectual property
rights; our ability to access capital markets; global political,
military, security or other instability; costs related to expansion
or other capital projects; interruption or breaches of information
technology systems; our ability to retain executive management and
key personnel; and our debt covenants.
These forward-looking statements are made only as of the date
hereof, and Stepan Company undertakes no obligation to update or
revise these forward-looking statements, whether as a result of new
information, future events or otherwise.
* * * * *
Tables follow
Table
I
|
STEPAN COMPANY For the Three and
Six Months Ended June 30, 2024 and 2023 (Unaudited – in
000's, except per share data)
|
|
|
|
Three Months
Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Net
Sales
|
|
$
|
556,405
|
|
|
$
|
579,975
|
|
|
$
|
1,107,823
|
|
|
$
|
1,231,411
|
|
Cost of
Sales
|
|
|
486,853
|
|
|
|
513,578
|
|
|
|
967,990
|
|
|
|
1,091,454
|
|
Gross
Profit
|
|
|
69,552
|
|
|
|
66,397
|
|
|
|
139,833
|
|
|
|
139,957
|
|
Operating
Expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling
|
|
|
11,828
|
|
|
|
11,109
|
|
|
|
23,216
|
|
|
|
24,176
|
|
Administrative
|
|
|
24,569
|
|
|
|
22,589
|
|
|
|
47,259
|
|
|
|
45,228
|
|
Research, Development
and Technical Services
|
|
|
14,093
|
|
|
|
14,105
|
|
|
|
28,349
|
|
|
|
29,243
|
|
Deferred Compensation
Expense
|
|
|
395
|
|
|
|
743
|
|
|
|
2,173
|
|
|
|
2,245
|
|
|
|
|
50,885
|
|
|
|
48,546
|
|
|
|
100,997
|
|
|
|
100,892
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Business Restructuring
Expense
|
|
|
-
|
|
|
|
42
|
|
|
|
-
|
|
|
|
199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Income
|
|
|
18,667
|
|
|
|
17,809
|
|
|
|
38,836
|
|
|
|
38,866
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other Income
(Expense):
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest,
Net
|
|
|
(2,661)
|
|
|
|
(3,865)
|
|
|
|
(5,732)
|
|
|
|
(6,687)
|
|
Other, Net
|
|
|
1,200
|
|
|
|
2,370
|
|
|
|
3,562
|
|
|
|
4,038
|
|
|
|
|
(1,461)
|
|
|
|
(1,495)
|
|
|
|
(2,170)
|
|
|
|
(2,649)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Before
Provision for Income Taxes
|
|
|
17,206
|
|
|
|
16,314
|
|
|
|
36,666
|
|
|
|
36,217
|
|
Provision for Income
Taxes
|
|
|
7,685
|
|
|
|
3,630
|
|
|
|
13,252
|
|
|
|
7,391
|
|
Net
Income
|
|
|
9,521
|
|
|
|
12,684
|
|
|
|
23,414
|
|
|
|
28,826
|
|
Net Income Per
Common Share
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.42
|
|
|
$
|
0.56
|
|
|
$
|
1.03
|
|
|
$
|
1.27
|
|
Diluted
|
|
$
|
0.42
|
|
|
$
|
0.55
|
|
|
$
|
1.02
|
|
|
$
|
1.25
|
|
Shares Used to
Compute Net Income Per
Common Share
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
|
22,827
|
|
|
|
22,768
|
|
|
|
22,825
|
|
|
|
22,763
|
|
Diluted
|
|
|
22,936
|
|
|
|
22,945
|
|
|
|
22,942
|
|
|
|
22,970
|
|
Table
II
|
Reconciliation of
Non-GAAP Net Income and Earnings per Diluted Share*
|
|
|
|
Three Months
Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
($ in thousands,
except per share amounts)
|
|
2024
|
|
|
EPS
|
|
|
2023
|
|
|
EPS
|
|
|
2024
|
|
|
EPS
|
|
|
2023
|
|
|
EPS
|
|
Net Income
Reported
|
|
$
|
9,521
|
|
|
$
|
0.42
|
|
|
$
|
12,684
|
|
|
$
|
0.55
|
|
|
$
|
23,414
|
|
|
$
|
1.02
|
|
|
$
|
28,826
|
|
|
$
|
1.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
Compensation
Income
|
|
$
|
(305)
|
|
|
$
|
(0.01)
|
|
|
$
|
(653)
|
|
|
$
|
(0.02)
|
|
|
$
|
(693)
|
|
|
$
|
(0.03)
|
|
|
$
|
(757)
|
|
|
$
|
(0.03)
|
|
Business Restructuring
Expense
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
31
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
146
|
|
|
$
|
0.01
|
|
Cash-Settled SARs
Income
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(44)
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(84)
|
|
|
$
|
-
|
|
Environmental
Remediation
Expense
|
|
$
|
180
|
|
|
$
|
-
|
|
|
$
|
39
|
|
|
$
|
-
|
|
|
$
|
1,331
|
|
|
$
|
0.06
|
|
|
$
|
345
|
|
|
$
|
0.01
|
|
Adjusted Net
Income
|
|
$
|
9,396
|
|
|
$
|
0.41
|
|
|
$
|
12,057
|
|
|
$
|
0.53
|
|
|
$
|
24,052
|
|
|
$
|
1.05
|
|
|
$
|
28,476
|
|
|
$
|
1.24
|
|
|
|
*
|
All amounts in this
table are presented after-tax
|
The Company believes that certain non-GAAP measures, in
conjunction with comparable GAAP measures, are useful for
evaluating the Company's operating performance and financial
condition. The Company uses this non-GAAP information as an
indicator of business performance and evaluates management's
effectiveness with specific reference to these indicators.
Management believes that these non-GAAP financial measures provide
useful supplemental information because they exclude
non-operational items that affect comparability between
years. These measures should be considered in addition to,
not as substitutes for or superior to, measures of financial
performance prepared in accordance with GAAP and may differ from
similarly titled measures presented by other companies. The
Company's Annual Report on Form 10-K for the year ended
December 31, 2023 contains additional
information regarding the use of non-GAAP financial measures.
Summary of Second Quarter 2024 Adjusted Net Income
Items
Adjusted net income excludes non-operational deferred
compensation income/expense, cash-settled SARs income/expense,
certain environmental remediation costs and other significant and
infrequent or non-recurring items.
- Deferred Compensation: The second quarter of 2024
reported net income includes $0.3
million of after-tax income versus $0.7 million of after-tax income in the prior
year.
- Environmental Remediation – The second quarter of 2024
reported net income includes $0.2
million of after-tax expense versus less than $0.1 million of after-tax expense in the prior
year.
Table
III
|
Reconciliation of
Pre-Tax to After-Tax Adjustments
|
|
Management uses the
non-GAAP adjusted net income metric to evaluate the
Company's operating performance. Management excludes the
items listed in the table below because they are non-operational
items. The cumulative tax effect was calculated using the
statutory tax rates for the jurisdictions in which the transactions
occurred.
|
|
|
|
Three Months
Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
($ in thousands,
except per share amounts)
|
|
2024
|
|
|
EPS
|
|
|
2023
|
|
|
EPS
|
|
|
2024
|
|
|
EPS
|
|
|
2023
|
|
|
EPS
|
|
Pre-Tax
Adjustments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
Compensation
Income
|
|
$
|
(407)
|
|
|
|
|
|
$
|
(871)
|
|
|
|
|
|
$
|
(924)
|
|
|
|
|
|
$
|
(1,009)
|
|
|
|
|
Business Restructuring
Expense
|
|
$
|
-
|
|
|
|
|
|
$
|
42
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
$
|
199
|
|
|
|
|
Cash-Settled SARs
Income
|
|
$
|
-
|
|
|
|
|
|
$
|
(58)
|
|
|
|
|
|
$
|
-
|
|
|
|
|
|
$
|
(111)
|
|
|
|
|
Environmental
Remediation
Expense
|
|
$
|
240
|
|
|
|
|
|
$
|
52
|
|
|
|
|
|
$
|
1,774
|
|
|
|
|
|
$
|
461
|
|
|
|
|
Total
Pre-Tax Adjustments
|
|
$
|
(167)
|
|
|
|
|
|
$
|
(835)
|
|
|
|
|
|
$
|
850
|
|
|
|
|
|
$
|
(460)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cumulative Tax
Effect
on Adjustments
|
|
$
|
42
|
|
|
|
|
|
$
|
208
|
|
|
|
|
|
$
|
(212)
|
|
|
|
|
|
$
|
110
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
After-Tax
Adjustments
|
|
$
|
(125)
|
|
|
$
|
-
|
|
|
$
|
(627)
|
|
|
$
|
(0.02)
|
|
|
$
|
638
|
|
|
$
|
0.03
|
|
|
$
|
(350)
|
|
|
$
|
(0.01)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table
IV
|
Deferred
Compensation Plans
|
|
The full effect of the
deferred compensation plans on quarterly pre-tax income was $0.4
million of income versus $0.9 million of income in the prior
year. The quarter-end market prices of Company stock and the
impact of deferred compensation on specific income statement line
items is summarized below:
|
|
|
|
2024
|
|
|
2023
|
|
|
|
6/30
|
|
|
3/31
|
|
|
12/31
|
|
|
9/30
|
|
|
6/30
|
|
|
3/31
|
|
Stepan
Company
|
|
$
|
83.96
|
|
|
$
|
90.04
|
|
|
$
|
94.55
|
|
|
$
|
74.97
|
|
|
$
|
95.56
|
|
|
$
|
103.03
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
($ in
thousands)
|
|
2024
|
|
|
2023
|
|
|
2024
|
|
|
2023
|
|
Deferred
Compensation
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
Expense
|
|
$
|
(395)
|
|
|
$
|
(743)
|
|
|
$
|
(2,173)
|
|
|
$
|
(2,245)
|
|
Other, net – Mutual
Fund Gain
|
|
|
802
|
|
|
|
1,614
|
|
|
|
3,097
|
|
|
|
3,254
|
|
Total
Pre-Tax
|
|
$
|
407
|
|
|
$
|
871
|
|
|
$
|
924
|
|
|
$
|
1,009
|
|
Total
After-Tax
|
|
$
|
305
|
|
|
$
|
653
|
|
|
$
|
693
|
|
|
$
|
757
|
|
Effects of Foreign
Currency Translation
|
|
The Company's foreign
subsidiaries transact business and report financial results in
their respective local currencies. These results are translated
into U.S. dollars at average foreign exchange rates
appropriate for the reporting period. The table below
presents the impact that foreign currency translation had on select
income statement line items.
|
|
($ in
millions)
|
|
Three Months
Ended
June 30,
|
|
|
Change
|
|
|
Change
Due to
Foreign
Currency
Translation
|
|
|
Six Months Ended
June 30,
|
|
|
Change
|
|
|
Change
Due to
Foreign
Currency
Translation
|
|
|
|
2024
|
|
|
2023
|
|
|
|
|
|
|
|
|
2024
|
|
|
2023
|
|
|
|
|
|
|
|
Net Sales
|
|
$
|
556.4
|
|
|
$
|
580.0
|
|
|
$
|
(23.6)
|
|
|
$
|
0.8
|
|
|
$
|
1,107.8
|
|
|
$
|
1,231.4
|
|
|
$
|
(123.6)
|
|
|
$
|
12.6
|
|
Gross Profit
|
|
|
69.6
|
|
|
|
66.4
|
|
|
$
|
3.2
|
|
|
|
(0.2)
|
|
|
|
139.8
|
|
|
|
140.0
|
|
|
$
|
(0.2)
|
|
|
|
1.1
|
|
Operating
Income
|
|
|
18.7
|
|
|
|
17.8
|
|
|
$
|
0.9
|
|
|
|
-
|
|
|
|
38.8
|
|
|
|
38.9
|
|
|
$
|
(0.1)
|
|
|
|
0.6
|
|
Pretax
Income
|
|
|
17.2
|
|
|
|
16.3
|
|
|
$
|
0.9
|
|
|
|
(0.1)
|
|
|
|
36.7
|
|
|
|
36.2
|
|
|
$
|
0.5
|
|
|
|
0.5
|
|
Corporate
Expenses
|
|
|
|
Three Months
Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
($ in
thousands)
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
|
2024
|
|
|
2023
|
|
|
%
Change
|
|
Total Corporate
Expenses
|
|
$
|
19,311
|
|
|
$
|
17,424
|
|
|
|
11
|
%
|
|
$
|
37,872
|
|
|
$
|
35,957
|
|
|
|
5
|
%
|
Less:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
Compensation Expense
|
|
$
|
395
|
|
|
$
|
743
|
|
|
|
(47)
|
%
|
|
$
|
2,173
|
|
|
$
|
2,245
|
|
|
|
(3)
|
%
|
Business
Restructuring Expense
|
|
$
|
-
|
|
|
$
|
42
|
|
|
|
(100)
|
%
|
|
$
|
-
|
|
|
$
|
199
|
|
|
|
(100)
|
%
|
Environmental Remediation
Expense
|
|
$
|
240
|
|
|
$
|
52
|
|
|
|
362
|
%
|
|
$
|
1,774
|
|
|
$
|
461
|
|
|
|
285
|
%
|
Adjusted Corporate
Expenses
|
|
$
|
18,676
|
|
|
$
|
16,587
|
|
|
|
13
|
%
|
|
$
|
33,925
|
|
|
$
|
33,052
|
|
|
|
3
|
%
|
Adjusted Corporate expenses increased $2.1 million, or 13% for the quarter. This
increase was primarily due to $3.5
million of higher expenses associated with a criminal social
engineering scheme at one of the Company's subsidiaries in
Asia, partially offset by
productivity measures implemented in late 2023.
Table V
|
Stepan Company Consolidated Balance
Sheets June 30, 2024 and December 31,
2023
|
|
|
|
June 30,
2024
|
|
|
December 31,
2023
|
|
ASSETS
|
|
|
|
|
|
|
Current
Assets
|
|
$
|
867,140
|
|
|
$
|
851,883
|
|
Property, Plant &
Equipment, Net
|
|
|
1,195,117
|
|
|
|
1,206,665
|
|
Other Assets
|
|
|
286,333
|
|
|
|
304,806
|
|
Total Assets
|
|
$
|
2,348,590
|
|
|
$
|
2,363,354
|
|
LIABILITIES AND
STOCKHOLDERS' EQUITY
|
|
|
|
|
|
|
Current
Liabilities
|
|
$
|
655,195
|
|
|
$
|
607,870
|
|
Deferred Income
Taxes
|
|
|
10,224
|
|
|
|
10,373
|
|
Long-term
Debt
|
|
|
374,708
|
|
|
|
401,248
|
|
Other Non-current
Liabilities
|
|
|
116,027
|
|
|
|
127,373
|
|
Total Stepan Company
Stockholders' Equity
|
|
|
1,192,436
|
|
|
|
1,216,490
|
|
Total Liabilities and
Stockholders' Equity
|
|
$
|
2,348,590
|
|
|
$
|
2,363,354
|
|
Selected Balance
Sheet Information
|
|
The Company's total
debt increased by $11.1 million and cash decreased by $1.1 million
versus March 31, 2024. The increase in debt primarily
reflects higher borrowings against the Company's revolving credit
facility that were partially offset by scheduled debt
repayments. The Company's net debt level increased $12.2
million versus March 31, 2024 and the net debt ratio increased from
30% to 31% in the quarter (Net Debt and Net
Debt Ratios are non-GAAP
measures, reconciliations of which are shown in the table
below). Management uses the non-GAAP net debt metric to show
a more complete picture of the Company's overall liquidity,
financial flexibility and leverage level.
|
|
($ in
millions)
|
|
June 30,
2024
|
|
|
March 31,
2024
|
|
|
December 31,
2023
|
|
Net Debt
|
|
|
|
|
|
|
|
|
|
Total Debt
|
|
$
|
657.1
|
|
|
$
|
646.0
|
|
|
$
|
654.1
|
|
Cash
|
|
|
124.7
|
|
|
|
125.8
|
|
|
|
129.8
|
|
Net Debt
|
|
$
|
532.4
|
|
|
$
|
520.2
|
|
|
$
|
524.3
|
|
Equity
|
|
|
1,192.4
|
|
|
|
1,214.5
|
|
|
|
1,216.5
|
|
Net Debt +
Equity
|
|
$
|
1,724.8
|
|
|
$
|
1,734.7
|
|
|
$
|
1,740.8
|
|
Net Debt / (Net Debt +
Equity)
|
|
|
31
|
%
|
|
|
30
|
%
|
|
|
30
|
%
|
The major working
capital components were:
|
|
($ in
millions)
|
|
June 30,
2024
|
|
|
March 31,
2024
|
|
|
December 31,
2023
|
|
Net
Receivables
|
|
$
|
437.3
|
|
|
$
|
446.6
|
|
|
$
|
422.1
|
|
Inventories
|
|
|
266.0
|
|
|
|
257.1
|
|
|
|
265.6
|
|
Accounts
Payable
|
|
|
(251.2)
|
|
|
|
(256.9)
|
|
|
|
(233.0)
|
|
|
|
$
|
452.1
|
|
|
$
|
446.8
|
|
|
$
|
454.7
|
|
Table
VI
|
Reconciliations of Non-GAAP EBITDA and
Adjusted EBITDA to Operating Income
|
|
Management uses the
non-GAAP EBITDA and adjusted EBITDA metrics to evaluate the
Company's operating performance. Management excludes the
items listed in the table below because they are non-operational
items.
|
|
|
|
Three Months
Ended
June 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in
millions)
|
|
Surfactants
|
|
|
Polymers
|
|
|
Specialty
Products
|
|
|
Unallocated
Corporate
|
|
|
Consolidated
|
|
Operating
Income
|
|
$
|
17.1
|
|
|
$
|
13.6
|
|
|
$
|
7.3
|
|
|
$
|
(19.3)
|
|
|
$
|
18.7
|
|
Depreciation and Amortization
|
|
$
|
17.9
|
|
|
$
|
8.2
|
|
|
$
|
1.5
|
|
|
$
|
0.4
|
|
|
$
|
28.0
|
|
Other, Net
Income
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1.2
|
|
|
$
|
1.2
|
|
EBITDA
|
|
$
|
35.0
|
|
|
$
|
21.8
|
|
|
$
|
8.8
|
|
|
$
|
(17.7)
|
|
|
$
|
47.9
|
|
Deferred
Compensation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(0.4)
|
|
|
$
|
(0.4)
|
|
Environmental Remediation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
0.2
|
|
|
$
|
0.2
|
|
Adjusted
EBITDA
|
|
$
|
35.0
|
|
|
$
|
21.8
|
|
|
$
|
8.8
|
|
|
$
|
(17.9)
|
|
|
$
|
47.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months
Ended
June 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in
millions)
|
|
Surfactants
|
|
|
Polymers
|
|
|
Specialty
Products
|
|
|
Unallocated
Corporate
|
|
|
Consolidated
|
|
Operating
Income
|
|
$
|
15.1
|
|
|
$
|
16.3
|
|
|
$
|
3.8
|
|
|
$
|
(17.4)
|
|
|
$
|
17.8
|
|
Depreciation and Amortization
|
|
$
|
16.0
|
|
|
$
|
8.3
|
|
|
$
|
1.4
|
|
|
$
|
0.8
|
|
|
$
|
26.5
|
|
Other, Net
Income
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
2.4
|
|
|
$
|
2.4
|
|
EBITDA
|
|
$
|
31.1
|
|
|
$
|
24.6
|
|
|
$
|
5.2
|
|
|
$
|
(14.2)
|
|
|
$
|
46.7
|
|
Deferred
Compensation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(0.9)
|
|
|
$
|
(0.9)
|
|
Cash
Settled SARs
|
|
$
|
(0.1)
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(0.1)
|
|
Business
Restructuring
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
Environmental Remediation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
0.1
|
|
|
$
|
0.1
|
|
Adjusted
EBITDA
|
|
$
|
31.0
|
|
|
$
|
24.6
|
|
|
$
|
5.2
|
|
|
$
|
(15.0)
|
|
|
$
|
45.8
|
|
|
|
|
|
|
|
Six Months Ended
June 30, 2024
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in
millions)
|
|
Surfactants
|
|
|
Polymers
|
|
|
Specialty
Products
|
|
|
Unallocated
Corporate
|
|
|
Consolidated
|
|
Operating
Income
|
|
$
|
43.1
|
|
|
$
|
22.0
|
|
|
$
|
11.6
|
|
|
$
|
(37.9)
|
|
|
$
|
38.8
|
|
Depreciation and Amortization
|
|
$
|
35.5
|
|
|
$
|
16.2
|
|
|
$
|
3.0
|
|
|
$
|
0.9
|
|
|
$
|
55.6
|
|
Other, Net
Income
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
3.6
|
|
|
$
|
3.6
|
|
EBITDA
|
|
$
|
78.6
|
|
|
$
|
38.2
|
|
|
$
|
14.6
|
|
|
$
|
(33.4)
|
|
|
$
|
98.0
|
|
Deferred
Compensation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(0.9)
|
|
|
$
|
(0.9)
|
|
Environmental Remediation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
1.8
|
|
|
$
|
1.8
|
|
Adjusted
EBITDA
|
|
$
|
78.6
|
|
|
$
|
38.2
|
|
|
$
|
14.6
|
|
|
$
|
(32.5)
|
|
|
$
|
98.9
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Six Months Ended
June 30, 2023
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
($ in
millions)
|
|
Surfactants
|
|
|
Polymers
|
|
|
Specialty
Products
|
|
|
Unallocated
Corporate
|
|
|
Consolidated
|
|
Operating
Income
|
|
$
|
42.2
|
|
|
$
|
26.3
|
|
|
$
|
6.3
|
|
|
$
|
(35.9)
|
|
|
$
|
38.9
|
|
Depreciation and Amortization
|
|
$
|
31.3
|
|
|
$
|
16.6
|
|
|
$
|
2.8
|
|
|
$
|
1.3
|
|
|
$
|
52.0
|
|
Other, Net
Income (Expense)
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
4.0
|
|
|
$
|
4.0
|
|
EBITDA
|
|
$
|
73.5
|
|
|
$
|
42.9
|
|
|
$
|
9.1
|
|
|
$
|
(30.6)
|
|
|
$
|
94.9
|
|
Deferred
Compensation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(1.0)
|
|
|
$
|
(1.0)
|
|
Cash
Settled SARs
|
|
$
|
(0.1)
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
(0.1)
|
|
Business
Restructuring
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
0.2
|
|
|
$
|
0.2
|
|
Environmental Remediation
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
0.5
|
|
|
$
|
0.5
|
|
Adjusted
EBITDA
|
|
$
|
73.4
|
|
|
$
|
42.9
|
|
|
$
|
9.1
|
|
|
$
|
(30.9)
|
|
|
$
|
94.5
|
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/stepan-reports-second-quarter-2024-results-302210820.html
SOURCE Stepan Company